Last updated: 9 September 2024 at 10:48am EST

Charles Farkas Net Worth




The estimated Net Worth of Charles Farkas is at least $1.53 million dollars as of 5 September 2024. Charles Farkas owns over 1,000 units of Conmed stock worth over $1,531,966 and over the last 10 years Charles sold CNMD stock worth over $0.

Charles Farkas CNMD stock SEC Form 4 insiders trading

Charles has made over 25 trades of the Conmed stock since 2015, according to the Form 4 filled with the SEC. Most recently Charles exercised 1,000 units of CNMD stock worth $39,640 on 5 September 2024.

The largest trade Charles's ever made was exercising 3,000 units of Conmed stock on 1 June 2016 worth over $220,110. On average, Charles trades about 931 units every 133 days since 2014. As of 5 September 2024 Charles still owns at least 20,880 units of Conmed stock.

You can see the complete history of Charles Farkas stock trades at the bottom of the page.



What's Charles Farkas's mailing address?

Charles's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti et Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.



What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500



Complete history of Charles Farkas stock trades at Conmed

Initié
Trans.
Transaction
Prix ​​total
Charles Farkas
Directeur
Exercice d'option $39,640
5 Sep 2024
Charles Farkas
Directeur
Exercice d'option $23,085
31 May 2024
Charles Farkas
Directeur
Exercice d'option $41,470
1 Jun 2023
Charles Farkas
Directeur
Exercice d'option $90,773
1 Jun 2022
Charles Farkas
Directeur
Exercice d'option $210,582
1 Jun 2021
Charles Farkas
Directeur
Exercice d'option $104,034
1 Jun 2020
Charles Farkas
Directeur
Exercice d'option $131,102
31 May 2019
Charles Farkas
Directeur
Exercice d'option $149,588
1 Jun 2018
Charles Farkas
Directeur
Acheter $7,996
3 Jan 2018
Charles Farkas
Directeur
Acheter $7,986
3 Oct 2017
Charles Farkas
Directeur
Acheter $7,972
5 Jul 2017
Charles Farkas
Directeur
Exercice d'option $142,154
1 Jun 2017
Charles Farkas
Directeur
Acheter $7,994
3 Apr 2017
Charles Farkas
Directeur
Acheter $13,618
3 Jan 2017
Charles Farkas
Directeur
Acheter $13,453
3 Oct 2016
Charles Farkas
Directeur
Acheter $13,499
1 Jul 2016
Charles Farkas
Directeur
Exercice d'option $123,180
1 Jun 2016
Charles Farkas
Directeur
Exercice d'option $123,180
1 Jun 2016
Charles Farkas
Directeur
Acheter $14,210
1 Apr 2016
Charles Farkas
Directeur
Acheter $14,210
1 Apr 2016
Charles Farkas
Directeur
Acheter $14,004
4 Jan 2016
Charles Farkas
Directeur
Acheter $13,940
1 Oct 2015
Charles Farkas
Directeur
Acheter $12,025
2 Jul 2015
Charles Farkas
Directeur
Exercice d'option $167,100
1 Jun 2015
Charles Farkas
Directeur
Acheter $11,924
1 Apr 2015


Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include: